Pharmaceutical Commerce - May/June 2017

Cutting Edge report finds continued growth in headcount

Compliance officers at pharma companies need to ensure that the right mechanisms are in place for monitoring sales and business incentives

Pallet-size, powered containers provide more options for less-than-truckload shipping

Traceability efforts forge ahead, anticounterfeiting technologies are reviving, and cargo security becomes a more settled practice

Annual industry competition highlights the adherence benefits of unit-dose packaging

Paper validation records will disappear in the face of continuous validation

Marketing strategies will adjust with the advent of biosimilars

An ‘overwhelming’ information load is affecting oncology’s ability to develop successful treatment pathways

Taking on the breadth of challenges in contract development and manufacturing, globally

Hubs and other patient services need to stress the personal

Pharmaceutical Commerce’s annual Cold Chain Sourcebook projects moderating growth of 38% between 2015 and 2021

Latest QuintilesIMS report sees 5.8% growth in 2016; more emphasis on ‘net-price’ spending

Fast reimbursement of trial subjects—a boost to trial participation—is compromised

EMD Serono Specialty Digest finds they struggle over 'ensuring clinically appropriate use'

UPS-owned subsidiary expands its direct-to-patient clinical services

Software/data offering will unify a ‘molecule to market’ solution for life sciences companies

The TransCelerate consortium is an early adopter

Acquisition of PharmaMetrics adds payer analytics to Integrichain’s channel, pharmacy intelligence

‘Why fund your competitors?’ asks the company, in a pitch to independents served by the Big 3 wholesalers

Less drug waste, fewer ER visits can offset high drug costs

Earns a “50+ Innovation Leader” award by AARP and MedCity News

Cutting Edge report finds continued growth in headcount

A growing process burden is forcing a modernized approach

Reimbursement is just one of the issues facing biosimilar commercialization in the US